<DOC>
	<DOC>NCT01106066</DOC>
	<brief_summary>To evaluate the efficacy of preoperative S-1/oxaliplatin/RT in locally advanced gastric cancer</brief_summary>
	<brief_title>Phase I/II Study of Neoadjuvant Chemoradiotherapy With S-1/ Oxaliplatin in Patients With Gastric Cancer: Randomized Phase II Study of S-1/RT vs. S-1/Oxaliplatin/RT</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Patients older than 18 years Patients with localized, histologically confirmed gastric or gastroesophageal adenocarcinoma ③ Localized gastric cancer of clinical stage (T2N(+), T3/T4) ECOG performance status of 0 to 1 ⑤ Adequate organ function as evidenced by the following; Absolute neutrophil count &gt; 1.5 x 109/L; platelets &gt; 100 x 109/L; total bilirubin ≤1.5 UNL; AST and/or ALT &lt; 5 UNL; creatinine clearance ≥ 50mL/min ⑥ Written informed consent form T1 (regardless of N stage), T2N0 M1 ③ Peritoneal seeding ④ Uncontrolled medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>